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Abstract
Both coagulation factor XIII-A2 (FXIII-A2) and tissue transglutaminase (TG2) play distinctive and
important roles in homeostasis by crosslinking proteins or peptides via isopeptide bonds. In this
present study, a series of microsecond long all-atom molecular dynamics (MD) simulations were
carried  out  in  order  to  reveal  the  dynamic,  atomic-level  events  which  may  contribute  to  the
activation of these proteins via the binding of calcium ions. In addition to previously conducted in
vitro and  crystallographic  studies,  further  suggestions  have  been  made  concerning  the  calcium
binding features of these enzymes. The different systems used for running the simulations were
based on the zymogen, computationally cleaved and even the activation peptide (AP-FXIII) free
FXIII-A2’ homodimer form. The effects of various ionic environments have also been explored in
the  simulations  of  FXIII-A2.  Our  results  suggest  that  the  presence  of  calcium ions  can  cause
increased AP fluctuations, which ultimately could lead to their relocation on the homodimer surface.
The release of these APs seem to be crucial for rotation of the A subunits based on equilibrium MD
simulations.  The  primary  evidence  for  this  assumption  comes  from  the  predicted  principal
component eigenvector what is considered as the first, large scale event of the overall activation
process. To get a more accurate atomic-level description, the calcium binding sites of TG2 have also
been  investigated  in  our  extensive  in  silico experiments,  which  suggests  the  presence  of  a
previously unidentified binding sites as well.
KEYWORDS: blood coagulation  factor  XIII,  FXIII-A2,  tissue  transglutaminase,  TG2,  calcium
binding, molecular dynamics simulation
List of Abbreviations
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Introduction
Both blood coagulation factor XIII subunit A (FXIII-A) and tissue transglutaminase (TG2)
are  protein-glutamine  gamma-glutamyltransferase  enzymes  (EC 2.3.2.13).  In  the  plasma,  FXIII
(pFXIII)  is  circulating  as  a  heterotetramer  with  two carrier  B subunits  (FXIII-A2B2),  while  its
cellular  form  (cFXIII)  exists  as  a  homodimer  (FXIII-A2)  in  the  cytoplasm  of  platelets  and
monocytes.  The  pFXIII  requires  proteolytic  activation  by  thrombin  (Lorand  & Konishi,  1964)
which cleaves the peptide bond between Arg37 and Gly38 of FXIII-A2. This cleavage then provides
the  activation  peptides  (here  denoted  as:  APs)  and  the  FXIII-A2’ (Takagi  &  Doolittle,  1974).
Crystallographic studies suggest that the cleaved N-terminal peptides remain attached to the surface
of the bovine α-thrombin activated homodimer form (Yee, Pedersen, Bishop, Stenkamp, & Teller,
1995),  blocking  the  entrance  to  the  cavities  where  the  catalytic  residues  are  located  (Cys314,
His373, Asp396) (Pedersen et al., 1994). It has been previously noted that pFXIII can be activated
without proteolytic cleavage under non-physiological conditions using high Ca2+ concentration (≥
50  mM) (Credo,  Curtis,  & Lorand,  1978).  Whereas  the  cellular  FXIII  (cFXIII),  derived  from
placenta, can be activated either proteolitically by thrombin and low Ca2+ level or with high sodium-
chloride (NaCl) or potassium-chloride (KCl) concentration in the presence of 2 mM Ca2+. Even in
the absence of any Ca2+ a  slow progressive activation can still  be observed (Polgár,  Hidasi,  &
Muszbek, 1990). Based on resolved active TG2 structure (Pinkas, Strop, Brunger, & Khosla, 2007)
large conformational changes were predicted to be able to obtain the enzymatically active FXIII-
A2* form (Komáromi, Bagoly, & Muszbek, 2011). Such major domain motions were published by
Stieler  et  al.  where  the  recombinant  cellular  FXIII  (rcFXIII)  was  activated  without  proteolytic
cleavage  (FXIII-Ao)  using  300  mM  sodium-chloride  and  3  mM  Ca2+ concentration.  The
displacement of β-barrel 1 and β-barrel 2 domains caused no major changes in the structure of the
other  two domains,  however  the  β-barrels  were  significantly  displaced  providing  an  accessible
catalytic cavity for substrate molecules (Stieler et al., 2013). Nevertheless, domain movements in
this structure differs from those that were suggested based on the analogy with TG2 (Komáromi et
al., 2011). In summary, calcium ions play a role in the dissociation of FXIII-B2 subunits from FXIII-
A2 and also to induce conformational activation of FXIII-A2. It was suggested that FXIII-A dimers
are responsible for Ca2+ binding (Km= 0.12 mM, based on fluorescence measurement) and were
estimated  to  bind  1.2-1.5  calcium  ions  based  on  equilibrium  dialysis  experiments  (Lewis,
Freyssinet, & Holbrook, 1978). The hypothesis also proposed the existence of two strong binding
sites  per  symmetrical  dimer,  along  with  some  other  weaker  binding  sites. Crystallographic
information can be found in the literature for the location of Ca2+ binding sites and even for binding
Sr2+ or  Yb3+.  Two symmetrical  Ca2+ and Sr2+ binding sites  can be found near  residues  Ala457,
Asn436,  Asp438,  Glu485 and Glu490.  It  is  worth noting,  that  in  the  crystallographic structure
published by Fox et al., there are eight Yb3+ ions present (Fox et al., 1999) with a total of four Yb3+
bound between the Asp270 and Asp271 residues of both monomer units. Interestingly, this is not
one of the known calcium binding sites, however a recently published active FXIII-A structure also
appears to contain a single Ca2+ bound to this site (Stieler et al., 2013). Site-directed mutagenesis
studies were carried out in order to validate the importance of the main binding site Glu485 and
Glu490 in  the  activation  process  and whether  residues  Asp476 and Asp479 play  a  role  in  the
conformational changes indirectly via a switch between the protease-sensitive and protease-resistant
form  (Lai,  Slaughter,  Peoples,  &  Greenberg,  1999). Surface  polarity  analysis  and  43Ca  NMR
experiments also suggest that weaker binding sites exist and the dissociation constant of calciums
for the zymogen FXIII-A2 is 0.51 mM. However, based on NMR experiments, in the presence of
thrombin the Kd increases significantly (5.9 mM) (Ambrus et al., 2001). Due to claims regarding
the limitations of NMR techniques, hydrogen/deuterium exchange experiments were conducted in
order  to  examine  the  percentage  of  deuteraion  of  four  different  FXIII-A2 systems  (zymogen,
thrombin-cleaved, thrombin cleaved + 1 mM Ca2+,  and the zymogen activated by 50 mM Ca2+)
using MALDI-TOF mass spectrometry, which resulted in the identification of several regions with
elevated deuteration (Turner & Maurer, 2002). The in vitro activated zymogen FXIII-Ao structure
has been published by Stieler et al. in the presence of a covalent inhibitor and using high ionic
strength. Within this study they have found that β-barrel 1 and β-barrel 2 undergoes remarkably
large movements and exposes its active site (Stieler et al., 2013). More recently a detailed structure/
function study has been conducted in which the generated pathway between the active and inactive
conformations were studied and the interaction between the A and B subunits was also modelled
(Gupta et al., 2016). More detailed information can be found about the structure and function of
FXIII  in  numerous  other  relevant  publications  (Komáromi  et  al.,  2011;  Lorand,  2001;  László
Muszbek, Bereczky, Bagoly, Komáromi, & Katona, 2011).
Tissue translgutaminase (TG2 or Gh protein), another member of the TG group of enzymes,
is  present  in  different  cellular  compartments  including  the  plasma membrane,  cytosol  and  the
nucleus, although only as a monomer. It is common for both TG2 and FXIII-A that activation only
occurs in the presence of Ca2+, however structural evidence is available in the absence of Ca2+ and
presence of GDP (Liu, Cerione, & Clardy, 2002), GTP (Jang et al., 2014) or ATP (Han et al., 2010).
The same lack of observed Ca2+ has been reported with the active conformation as well (Pinkas et
al., 2007). TG2 possesses GTPase activity and the binding of guanosine-phosphates regulates the
transamidation activity in a negative way. Interestingly, based on equilibrium dialysis experiments,
TG2 can bind up to  six  Ca2+ which can decrease with the binding of GTP (Bergamini,  1988).
Modest sequence homology can be observed between the eight known human TGs (Stieler et al.,
2013),  but  they  share  a  highly  conserved  secondary  and  tertiary  structure.  Using  the known
structure of FXIII-A2 (V. C. Yee et al., 1994), as a base template for homology modelling, 50 ps
unconstrained MD simulations were carried out in the absence of explicit solvent molecules both
with and without Ca2+ (3 pcs.). In this, it was suggested that the short simulation time and low
stoichiometric ratio were the main causes for the lack of large scale movements, although  both
simulations predicted that the added calciums would increase the gyration radius. When digesting
the enzyme in limited proteolysis experiments, it was found that only the loop region between the
catalytic and the first β-barrel domain has been cleaved (Casadio et al., 1999). Results of 43Ca NMR
investigations suggested the presence of some low affinity sites, more interestingly the Kd was
somewhat similar to the thrombin activated FXIII-A2 value (6.0 mM versus 5.9 mM), hence these
two enzymes probably follow a similar activation mechanism (Ambrus et al., 2001). In a detailed in
vitro experiment  five  calcium  binding  sites  were  identified  following  systematic  mutations  of
certain residues within the putative binding sites (Király et al., 2009). These sites were established
based on computer modelling and structural analogy with FXIII-A and epidermal translgutaminase
(TG3). It should be noted that the 1KV3 structure (Liu et al., 2002) contains a glycine residue in the
position  of  224  while  its  native  form  contains  valine  in  the  very  same  position
(https://www.uniprot.org/uniprot/P21980). As of now, there are no known structures available of the
native closed TG2 except 4PYG (Jang et al., 2014), which has the native Val224, but contains three
other  point  mutations,  and the  reasons behind these  were  not  discussed in  the  original  article.
Kanchan et al. pointed out, that there are several differences between the calcium affinity, GTPase
activity  and  other  measures  of  these  different  TG2  forms  (Kanchan  et  al.,  2013).  The  open
conformation of TG2 was resolved by Pinkas et al. via incubating the enzyme in 150 mM NaCl, 10
mM Ca2+ and in the presence of an irreversible,  modified-pentapeptide inhibitor  (Pinkas  et  al.,
2007). A recent review concerning the protein-protein interactions of the TG2 can be found in the
literature (Kanchan, Fuxreiter, & Fésüs, 2015). 
In  summary,  coagulation  factor  XIII  and TG2 represent  well  studied  systems,  however,
several details of their calcium induced activation process still remains unclear. In this present work
a series of microsecond long all-atom MD simulation were conducted on both the zymogen and on
the computationally cleaved FXIII-A2’, both in the presence and absence of Ca2+ cofactors and also
using activation peptide free proteins. Individual and combined effects of Ca2+ and GDP were also
considered in the study of TG2, then the outcomes of these MD simulations were compared to
existing  in vitro experimental results. The effect of the Gly224Val mutation on calcium binding
affinity and overall protein dynamics has also been investigated within this study. 
Materials and methods
The simulation systems
In order to examine the effect of Ca2+ on the dynamics of FXIII-A2, the following simulation
sets were assembled. The first simulation set (i) was used to study the zymogen enzyme via the
calcium bound form of FXIII-A2 (i/a) (PDB ID: 1GGU (Fox et al., 1999)) and in addition to the two
bound calcium ions, the total Ca2+ concentration was set to 14 mM. A second zymogen model was
created from the 1F13 PDB structure (i/b) (Weiss, Metzner, & Hilgenfeld, 1998) and a total of 50
mM Ca2+ was added into the simulation cell.  To clarify the important structural features of the
thrombin  treated  FXIII-A2’, the  peptide  bond  between  Arg37  and  Gly38  was  cleaved  using
computational methods and from these, four different model systems were constructed. The ii/a and
ii/b model systems were analogues of i/a and i/b, respectively. The ii/c model was similar to ii/b, but
contained only 14 mM Ca2+ (practically 20 calcium ions), while the final model of this set of four
contained only  the  neutralized protein  with a  total  of  150 mM NaCl (ii/d)  and was used as  a
reference. We have suspected that after the proteolysis of the APs, the next step in the activation
process  should  be  the  relocation  or  at  least  partial  dissociation  of  the  APs  in  the  presence  of
calcium.  The  simulations  in  the  absence  of  APs  (FXIII-A2’)  were  carried  out  under  different
conditions; with no calciums present at all (iii/a), with 14 mM Ca2+ (iii/b) and with 1000 mM Ca2+
(iii/c), in order to examine the protein dynamics under extreme ionic strength. The reason why we
chose ten times higher calcium concentration than in vivo (14 mM vs. 1.4 mM) was partially due to
computational  time  limitations.  To  address  this,  we  have  increased  the  number  of  interacting
calcium ions in order to reveal all possible binding sites within time frame, including previously
hypothesized weak ones. Further reinforcement for using 14 and 50 mM Ca2+ concentration came
from the results of MALDI MS experiments where these concentrations were sufficient to detect
changes in the percentage of deuteration (Turner & Maurer, 2002).
In the fourth simulation set individual and combined effects of calciums and guanosin di- or
triphosphates  were  studied  on  TG2  systems.  In  the  reference  simulation  the  bound  GDP was
removed and enzyme solvation was achieved in the presence of 150 mM NaCl (iv/a), and also
containing 8 mM Ca2+ (iv/b), which corresponds to 10 calcium ions. We have also repeated these
two  simulations  in  the  presence  of  GDP (iv/c,d)  as  well.  Due  to  the  suspected  importance  of
Gly224, the final model of this set (iv/e) was based on GTP bound TG2 in the presence of 6 mM
Ca2+ (practically 8 calcium ions). 
Table 1. Details of FXIII-A2 and TG2 simulation sets.
All  simulations  of  iv/a-d  were  based  on  the  1KV3  (Liu  et  al.,  2002)  crystallographic
structure,  however  iv/e  was  based on the  4PYG X-ray  structure  (Jang et  al.,  2014).  The  final
simulation set (v) contained the open conformation of the FXIII-AO monomer (PDB ID: 4KTY)
with three bound calcium ions (v/a) (Stieler et al., 2013) and the calcium free open conformation of
TG2 (v/b) (Pinkas et al., 2007). Both of these model systems contained 14 mM Ca2+ concentration
and were considered to be interesting cases, however they did not couple closely to any part of this
present study. Throughout the work we have numbered the residues according to existing literature
(id est the first methionine was omitted in the case of FXIII-A but not in the case of TG2) and the
recommended abbreviations of Muszbek et al. were used for factor XIII (L. Muszbek, Ariëns, &
Ichinose, 2007), where it was possible.
Molecular dynamics simulations
The protein models were solvated using explicit TIP3P water molecules in octahedral boxes
with the closest distance between the box and the protein being 12 Å. In the next step all systems
were  neutralized  and  the  NaCl  concentration  was  set  to  150  mM/dm3.  After  a  short  energy
minimization  step,  a  2  ns  long  simulated  annealing  equilibration  was  carried  out  where  the
minimized systems were heated up to 310 K and the protein heavy atoms were kept restrained by a
force  constant  of  1000  kJmol-1nm-2.  Following  the  equilibration  procedure,  model  system
dependent, one or two microsecond long (Table 1) isobaric-isothermal (NpT) production runs were
performed using periodic boundary conditions with the aid of virtual sites that allowed a 4 fs step
size for integrating the Newtonian laws of motions. All bonds were constrained using the LINCS
algorithm  (Hess,  Bekker,  Berendsen,  &  Fraaije,  1997).  In  simulations  where  guanine  di-  or
triphosphate was present, a 2 fs step size was applied and these simulations lasted 1 µs. A cut-off of
10.0 Å was used for the Lennard-Jones and short-range electrostatic interactions and a force-switch
was applied to smoothly switch forces between 7.0 Å and 10.0 Å. The long-range electrostatics
interactions were calculated by Particle Mesh Ewald summation. For the coupling of thermal bath
the velocity-rescaling method was used (Bussi, Donadio, & Parrinello, 2007), while pressure was
regulated  with  the  isotropic  Parrinello-Rahman  method  (Parrinello  &  Rahman,  1981).  The
Amber99SB-ILDN-NMR (Hornak et al., 2006; Li & Brüschweiler, 2010; Lindorff-Larsen et al.,
2010) force field (Hornak et al., 2006; Li & Brüschweiler, 2010; Lindorff-Larsen et al., 2010) was
used  throughout  the  simulations  since  it  was  successfully  used  in  the  study  of  calcium  and
magnesium binding features of small antifungal proteins (Fizil et al., 2018). In the systems where
TG2 was complexed with GDP or GTP the AMBER GAFF parameters  (Meagher,  Redman,  &
Carlson, 2003) were used for the substrates. A total of 21 µs all-atom MD simulations were carried
out in this study to be able to examine the details of the early events of calcium induced activation
of human TGs.
In two cases (ii/c and iv/d) an additional 50 ns NpT MD simulation was carried out with the
Amber ff14SB force field (Maier et al., 2015) and using multi-site Ca2+ models (Saxena & Sept,
2013)  in  order  to  simulate  more  precisely  the  already  established  binding  sites.  The  starting
structures were extracted from the very end of the corresponding simulations and all bound calcium
ions were kept as is.  If  any virtual interaction sites were present,  they were removed. The XZ
(central)  atom  of  the  multi-site  Ca2+ model  was  aligned  to  all  of  the  bound  calciums.  The
reconstructed systems were solvated in an octahedral box filled with TIP3P water molecules and the
final NaCl concentration was set  to 150 mmol/dm3.  A 10.0 Å cut-off was used over the initial
energy  minimization  step,  the  1.7  ns  long  (3-stage)  equilibration  protocol  and  the  50  ns  long
production runs. 
The MD simulations were performed using GROMACS 5.1.4 (Abraham et al., 2015; Páll,
Abraham, Kutzner, Hess, & Lindahl, 2015) and with the pmemd software of the Amber16 package
(Case et al., 2005; D.A. Case et al., 2016; Salomon-Ferrer, Case, & Walker, 2012). The trajectories
were analysed with the software tools of GROMACS and the cpptraj program (Roe & Cheatham,
2013). The dynamic cross-correlation matrices (DCCM) (McCammon, 1984) were calculated over
12.500 frames with the aid of the Bio3D v2.3 R package (Grant, Rodrigues, ElSawy, McCammon,
& Caves, 2006; R Core Team, 2013). R was used to perform all matrix operations as well. For
visualization of the protein structures either UCSF Chimera 1.11.2 software (Pettersen et al., 2004)
or Visual Molecular Dynamics (VMD) 1.9.1 (Humphrey, Dalke, & Schulten, 1996) was used. All
unresolved segments of the protein structures were reconstructed with MODELLER 9.10 and only
those models were used which had the best DOPE score (Šali & Blundell, 1993) via the graphical
unit interface of UCSF Chimera (Yang et al., 2012). It should be noted that the conformation of the
missing  loop  region  of  1GGU  (between  Thr508  and  Ser516)  was  found  to  have  an  overall
importance, therefore, it was remodelled as it can be found in the 1F13 structure with the loop of the
A chain of 1F13 placed to the B chain of 1GGU and vice versa. All of the data that can be seen in
this  present  work  was  plotted  by  various  in-house  written  Python  scripts  using  matplotlib
(Droettboom et al., 2018) and numpy (van der Walt, Colbert, & Varoquaux, 2011). The protonation
states of titratable residues were predicted using the H++ webserver (Anandakrishnan, Aguilar, &
Onufriev, 2012; Gordon et al., 2005; Myers, Grothaus, Narayanan, & Onufriev, 2006) at pH=7.4,
however, it should be noted that all of the aspartate and glutamate side-chains of the TG2 systems
were predicted to be deprotonated (i.e. negatively charged).
Analysis of molecular dynamics simulations
Frames of the dynamic trajectories were saved every 80 ps and contained the corresponding
protein plus Ca2+ ions and any GDP or GTP, if any were present. For the analysis of root mean
square deviation (RMSD), root mean square fluctuations (RMSF) and radius of gyration (rgyr), the
heavy atoms within the protein were used. In order to ensure that the N-terminal activation peptide
does not interfere our conclusions, the RMSD and rgyr values were calculated for residues between
Gly38 and Met731 in the case of FXIII-A2 simulations. For dimers, the per-residue averaged values
of RMSFs were calculated per individual chain and then averaged. For the calculation of DCCM
matrices the coordinates of Cα atoms were used which yielded symmetrical N x N matrices. Since
the interpretation of correlation matrices can be quite difficult in such a large proteins, we have tried
to  focus  only  on  the  difference  DCCM  matrices  ((cij(2)-cij(1),  where  cij(1)  was  taken  as  a
reference)), however all reference matrices are also included in the SI. The Ca2+ binding properties
were based on the calculation of distance between the Cγ atom of aspartate or the Cδ atom of
glutamate and any Ca2+. The large amplitude low frequency motions were extracted from the Cα
trajectory for principal component analysis and the first 10 eigenvectors were calculated via the
ProDy software (Bakan et al., 2014; Bakan, Meireles, & Bahar, 2011). For helping the interpretation
of the domain motions of monomers relative to each other, the centre of masses of main structural
domains  were  used  to  calculate  a  pseudo  torsion  angle  and  the  standard  deviations  were  also
indicated in each case.
Results and discussion
Results of molecular dynamics simulations
Simulations of FXIII-A2
Due to the complex nature of the activation mechanism of FXIII-A2, we followed a step-by-
step approach to clarify the key events which may contribute to an enzymatically active protein
conformation and can also be related to the binding of calcium. This meant starting from zymogen
structures (i/a,b) through proteolitically activated ones (ii/a-d) and finally simulating the AP free
proteins (iii/a-c). Since it was the very first instance where FXIII-A2 was studied by the means of
long MD simulations,  we have primarily  assessed the general  dynamic properties  (RMSD, rgyr,
RMSF) of these runs.
The root mean square deviations (Fig. 1) of zymogen and proteolitically activated FXIII-A2
models suggest that the presence of calcium ions in general increases the heavy atom RMSDs in
every case, compared to the reference simulation (ii/d). More importantly, on the timescale studied,
the  high  level  of  Ca2+ concentration  (50  mM)  does  not  appear  to  influence  the  dynamics
significantly, although it should be noted that these simulations converge much slower towards the
~2.5 Å final RMSD value, than any of the other ones. Therefore, we cannot exclude the importance
of high calcium concentration on a much longer timescale since the increased fluctuations of APs
are clearly demonstrated (see later).
The reason why dynamics of simulation sets i and ii are quite similar, lies in the presence of
the APs. Independently from the fact whether the APs are cleaved or not, it seems that their main
role is to keep the monomer subunits together. Since the fluctuations of the first 37 residues are
significantly smaller in the absence of calcium ions, it  is highly probable that calciums play an
essential role in releasing the APs. Two arginine residues (Arg11, Arg12) play a critical role in
holding the APs in their place, as it was found in earlier studies (László Muszbek et al., 2011).
These residues are located in a relatively deep cavity and several acidic residues (Asp343, Asp345,
Asp367 and Glu401) hold them in place via salt-bridge contacts. We assume that full dissociations
of the APs are rare events on the MD timescale, if they are possible at all, but in the ii/c simulation
we can observe a slight relocation of an arginine contained within one AP, however it does not
dissociate  completely.  The added calcium ions  increase  the  fluctuations  of  N-terminal  peptides
significantly  (Fig.  2),  contributing  directly  to  the  release  of  APs,  however  other  additional
requirements cannot be excluded at this stage. The 2 μs long simulations without APs (iii/a-c) shows long simulations without APs (iii/a-c) show
that the RMSDs increase in every scenario even in the absence of calcium ions. The detailed effect
of extremely high calcium concentration will be discussed in a different section.
In the context of gyration radius (Fig. S2), all of the studied zymogen and cleaved models
represent almost identical final values,  with the average radius of gyration of these simulations
being 36.90 ± 0.1 Å. The RMSD and rgyr were also calculated for each monomer chain and can be
found in the SI (Figure S1, S3).
Notable regions with high local RMSF are shown on (Figure S4-S6) and generally speaking
these  regions  are  loop  segments  or  located  in  close  proximity  to  the  terminals  of  the  AP.
Nevertheless we would like to highlight the possible importance of four regions which may have
distinguished significance.  These regions can be found between the residues of Val274-Asp280,
Met350-Trp370, Ile440-Ile460 and Pro505-Arg515. Other than the first segment, all of the others
are  situated  in  close  proximity  to  each  other.  The  loop  regions  between  Val274-Asp280 show
moderate fluctuations except for the third simulation set, where the RMSF values are significantly
higher. The second region is also in contact with sixteen residues of the other subunit N-terminal
and a helix can be found at the N-terminal end of the last region. This helix contains the residues of
the main Ca2+-binding site, hence an allosteric pathway can be drawn from the main binding site to
the AP. Since the residues between Pro505-Arg515 are usually poorly or non-resolved at  all  in
crystallographic structures, even in the 1F13 structure the subunits show different conformations in
these regions, one can obviously associate a regulatory function to these segments. The Met350-
Trp370,  Ile440-Ile460  regions  are  organized  in  three  adjacent  anti-parallel  β-strands  and  one
disordered  loop.  Despite  contradictions  in  the  details  of  the  proposed  activation  mechanisms
(Komáromi et  al.,  2011;  Stieler  et  al.,  2013) the above mentioned segments  should be equally
important in the movement of β-barrel 1. Simulation iii/c corroborate this theory, since the local
fluctuations are higher than in simulation i and ii and also a special monomer movement can be
observed within this system as well.
Our  findings  here  point  to  several  valid  conclusions;  (1)  the  presence  of  calcium ions
generally increases the RMSD values compared to the reference simulation; (2) in the absence of
APs slightly higher RMSD can be observed, however extremely high Ca2+ concentration causes a
significant increase in RMSD values; (3) the fluctuation of the N-terminal part of the APs were
greatly influenced by the presence of calciums.
Figure 1.  Heavy atom root mean square deviation during FXIII-A2 simulations.  (The activation
peptide was omitted in the calculation of RMSD in order to have comparable results.)
Figure 2. Per-residue averaged root mean square fluctuation of the activation peptide heavy atoms
during FXIII-A2 simulations.
Simulations of TG2
Following a similar  detailed approach for TG2 as in the case of FXIII-A2,  not  only the
individual  effects  of Ca2+ ions and guanosine-phosphates were studied,  but  also their  combined
effects via time-dependent properties.
Here we cannot observe notable differences in RMSD and rgyr values between iv/a and iv/b
simulations (both without GDP), however in the presence of GDP we can see clear differences in
RMSDs which follow the iv/a ~ iv/b > iv/d > iv/c trend (Fig. 3(A)). These results can be elucidated
by the GDP-bound forms being in vivo inactives and the smaller RMSDs can also be the sign of the
conservative behaviour of the inactive form. It should be noted here that the added calcium ions
obviously increase the RMSD, indicating their significance in creating an eventually active (open)
TGase  conformation.  The  rgyr values  in  this  case  are  much  higher  suggesting  that  the  parallel
occurrence of the Ca2+ ions and the GDP leads to different dynamics. The simulation using the
4PYG structure as a starting point (iv/e) also supports the hypothesis that has been stated in the case
of iv/d.  It  is  worth pointing out that after  650 ns the RMSD values of iv/e show an elevation,
probably  since  the  initial  structure  contains  three  point  mutations  (Gln186Glu,  Thr533Asn,
Val655Leu)  which  influence  the  dynamics  in  condensed phase.  The rgyr values  do not  indicate
significant changes, i.e. the protein remains stable and there are no signs of unfolding (Fig. 3(B)).
Due to the highly conserved secondary and tertiary structure of the inactive (closed) FXIII-
A2 and TG2 we can observe similarities in RMSF values (Fig. S7). The earlier highlighted regions
of FXIII-A2 correspond to the following residues in the TG2 structure: Ile313-Asn333, Val401-
Val422 and Asn460-Thr471 (according to the TG2 residue numbering). Indeed, these regions seem
to share many common features with the FXIII-A, thus we focus on the fine details between the
TG2 simulations by looking at the RMSF differences between the corresponding sets.
Figure 3. (A) Heavy atom root mean square deviation and (B) heavy atom radius of gyration during
TG2 simulations.
The graphical representation of the RMSF differences is shown in Figure S8. As it can be
seen, the largest  differences affect the β-sandwich domain,  however these discrepancies can be
attributed to regions with no known importance, such as Leu12-Lys30, Gly64-Gly72, Leu79-Asp87.
The region between Arg240-Tyr245 shows high fluctuation in the presence of Ca2+ (Fig. S8(A)),
although importance  of  this  segment  is  not  fully  understood.  More importantly,  the  active  site
Cys277 is concealed by this loop and a binding site can also be found near Asp232 and Asp233
(Asp270 and Asp271 in FXIII-A2). Since this loop most likely adapts an ordered conformation in
the active TG2 and FXIII-A2 as well, it is possible that it can control the opening of the active site
during activation not only in TG2, but also in FXIII-A2. The loop between Thr343-Glu352 also
shows high fluctuation, but only in the absence of calcium and GDP (Fig. S8, panel A, D). In the
presence of calcium ions this loop is fixed by a bound calcium, which seems like an acceptable
interpretation of the observed high fluctuation (iv/a).
Concerning  the  loop  region  between  Asn460-Thr471,  we  can  provide  the  following
plausible explanation. Despite the residues of the main binding site in FXIII-A2 (Asp438, Gly457,
Glu485, Glu490) being almost perfectly conserved in TG2 (Asp400, Ser419, Glu447, Glu452), we
can only assume, based on the above mentioned identities, that this site would actually bind any
calcium. Since the β-strand in FXIII-A (Thr449-Ile460) is partially disordered in TG2 (Ser411-
Val422), this assumption seems highly plausible indeed. On the other hand, the space available  in
TG2 is much wider than in FXIII-A2. Another possibility could be the formation of a binding site
under the helix which pulls it downward, hence strengthening the Asn460-Thr471 loop, just like
bending a note on a guitar string. The fluctuations only increased when there were calciums added
to the simulation box, meaning that the C-terminal end of this loop is connected to the β-barrel 1,
hence on a much longer timescale it may initiate more significant rearrangements, such as pulling
down the first β-barrel and turning both barrels upside down. This mechanism would be completely
in line with the “swiss army knife” theory for the activation of TGs (Komáromi et al., 2011).
Correlated motions
Due to the complex and large structure of these studied systems, it was deemed necessary to
inspect correlated motions within, in order to identify differences which may be in connection with
the presence of calciums and large scale domain movements during the activation process.
By taking the differences between the zymogen (i) and the cleaved (ii) simulation sets of
FXIII-A2, the main common feature that clearly appears is the strong correlation of the β-sandwich
and β-barrel 1 domains within the subunits. This positive correlation indicates the movement of the
domains in the same direction, thus these motions are practically the same as represented by the
principal component analysis in the next section. Taking the comparison of i/a and ii/a and also the
i/b and ii/b simulations several important features can be observed (Fig. S11). As mentioned above,
the  region  between  the  residues  of  Met350-Trp370  and  Ile440-Ile460  are  assumed  to  play  an
important  role  regardless  of  the  activation  mechanism,  meaning  that  these  regions  should  be
involved in both suggested processes. Supporting this hypothesis, these segments show increased
correlation with the β-barrel 1 and also with the very same segments of the other subunit in the
cleaved structures,  while  in the zymogen structures they seem much less correlated (Fig.  S11).
Another interesting observation is that these regions also correlate significantly with the residues
between Gly210-Trp225. This region is located next to the C-terminal end of the β-barrel 1 and the
N-terminal  of β-barrel  2 and also shows somewhat weaker correlation to these in the zymogen
models. The effects of bound calcium ions become evident when comparing ii/c and ii/d, where
their correlation to the β-sandwich domains can mainly be attributed to the presence of these bound
ions (Fig. S12(A)). A comparison of simulations starting from different PDB structures carried out
in the presence of 14 mM Ca2+ can be seen in Figure S11(B). Last but not least, all of the notable
correlations are present in the third simulation set as well and the extreme ionic strength causes
even higher correlation between the β-sandwich domains and strong anti-correlation between the β-
sandwich and the β-barrel domains (Fig. S13). These findings can predict the observed monomer
rotation and are in good agreement with the results of the PCAs.
Despite the well-preserved tertiary structures of FXIII-A2 and TG2, it is important to note
that  in  the  latter  the  β-barrel  1  is  correlated  with  the  β-sandwich and the  β-barrel  2  seems to
correlate rather with the core domain (Fig. S14), making it a unique feature of TG2. The second
notable difference can be found in the β-strand regions between the residues of Ile313-Asn333 and
Val401-Val422 (correspond to  the  Met350-Trp370  and Ile440-Ile460  in  FXIII-A2),  where  these
segments correlate with β-barrel 1 and also with the core domain, while in the case of FXIII-A2 we
cannot observe this latter correlation.
Concerning the simulation of open transglutaminases (v/a,b) the cross-correlation matrices
suggest a clear difference. Namely, in v/b (TG2, 2Q3Z) the β-barrel 2 is correlated with the β-
sandwich domain and is strongly anti-correlated with the core and β-barrel 1 domains (Fig. S15,
panel B). In the v/a (FXIII-Ao, 4KTY) we can observe exactly the opposite phenomena (Fig. S15,
panel A). To our current knowledge, we emphasize that either these enzymes follow two completely
different  activation mechanisms or one of  the open conformations was kinetically  trapped in a
transient state during the large scale motions.
Principal component analysis and the interdomain salt-bridge network
The large amplitude motions are usually difficult to visually detect even over longer MD
simulations,  therefore we have decided to examine these possible  motions in  another way.  The
calculated pseudo torsion angles of the dynamic centre of masses for corresponding domains can be
seen in Figure 4. Most of these dihedrals are distributed closely around -40° with one exception. In
the case of iii/c this value is approximately -70°, what means a further 30 degrees of rotation.
Interestingly,  the principal  component  analyses  of  iii/a-c  systems shows that  the motion
along the first eigenvector is in perfect agreement with our findings in the case of iii/c and with the
domain correlations discussed before. The high Ca2+ concentration induced monomer rotation from
the  MD  trajectory  also  can  be  observed  in  the  PCA analysis  as  the  first  eigenvector  in  each
simulation (Fig. 5(A)). It is important to point out that in the presence of the AP, these eigenvectors
are  hardly  present  at  all  or  are  significantly  smaller,  which  provides  further  evidence  on  the
protective roles of APs. Moreover, these findings support the experimental results which suggest
that  a  slow  progressive  activation  occurs  and  also  that  added  calciums  increase  the  speed  of
activation for the zymogen FXIII-A2. Since these motions are not visible in the presence of APs, it
can be assumed that the relocation of the N-terminal part of the AP is necessary for the activation,
which is in agreement with the enhanced fluctuations of these regions. The rotation takes place as a
contrary motion of the subunits involved, where the axis perpendicular to the plane of the paper
goes through an interdomain salt-bridge network (Fig. 5(B)). This salt-bridge network has been
never  discussed previously,  and a  graphical  representation  can  be  seen in  Figure S14 with the
characteristic distances also depicted. The Asp404, Asp427 and the Arg260, Arg408 residues of both
subunits  play  a  role  in  the  formation  of  this  salt-bridge  network  and  despite  the  significant
movement these contacts remain stable, excluding minor differences in the case of iii/c.
Moreover,  it  was  found earlier  that  the  mutation  of  Arg260 causes  serious  deficiencies,
therefore  the  effect  of  this  mutation  was  also  investigated  by  computational  means  and  then
compared to the energies of optimized structures (Ichinose et al., 1998; Peyvandi et al., 2004). Our
results suggest that after 1 μs long simulations without APs (iii/a-c) shows simulation time the subunits do not suffer significant changes, despite
the obvious fact  that  Cys260 was unable to  establish any native contacts  (Fig.  S10).  It  is  also
possible that this mutations causes structural changes within the A subunit, hence after folding the
native dimer could not be formed. Last but not least,  an interesting difference can be observed
between the sequences of FXIII-A and TG2. It has been identified that Arg408 is not conserved in
TG2, but Cys370 can be found in this exact position, which can lead to the conclusion that the
Arg260Cys can cause serious malfunction and the subunits are unable to assemble. Based on this
analogy, the Cys370 could then be the reason why TG2 preserves its monomer structure  in vivo.
Structurally,  Cys370 and Cys371 residues  are  important  and are  known as  a  disulphide switch
which helps to stabilize the active (open) conformation of TG2.
Figure 4. (A), the calculated pseudo torsion angles in the FXIII-A2 simulations. The black vertical
lines on the top of bars show the standard deviation. (B), result of the iii/c simulation (FXIII-A2),
the first frame of the trajectory (left side) compared to the last frame (right side).
Figure 5. (A), the first principal component analysis eigenvectors of the C-alpha trajectories. (B),
the  central,  inter-subunit  salt-bridge  network  and its  location.  (The colouring  of  the  secondary
structure  of  FXIII-A2 correspond  to  the  structural  elements  (purple=α-helix,  yellow=β-sheet,
blue=310 helix), the residues of central salt-bridge network was shown with sticks.)
Calcium binding
FXIII-A2
It was known that FXIII-A2 can bind one calcium per A subunit and several structures can be
found in the Protein Data Bank that contain di- or trivalent cations bound to FXIII-A 2, eg. 1GGU,
1GGY, 1QRK, 1EVU (Fox et al., 1999). Based on these studies, factor XIII-A2 can bind only one
Ca2+ or Sr2+ per subunit in the very same binding site (Asp438, Gly457, Glu485, Glu490) and can
accommodate up to eight Yb3+ in three binding sites (4 Yb3+ - chain A/B Asp270, Asp271, Glu272; 2
Yb3+ - chain B: Asp438, Glu485, Glu490; 1 Yb3+ - chain A: Asp438, Glu485, Glu490; 1 Yb3+ - chain
A: Asp574, Glu585). It is worth noting that the 4KTY X-ray structure of the open FXIII-AO also
contains three calcium ions. One of them is located in the main binding site (Asp438, Gly457,
Glu485,  Glu490),  the second bound by Asp270 and Asp271, and the third bound calcium was
accommodated by the side chains of Asp343, Asp345, Asp351 and Asp367. The last one is buried in
the closed (inactive) FXIII-A2 by the APs, which could explain why it was unoccupied in the case
of Yb3+ ions. On the other hand, these three occupied sites seem to be well conserved features, since
they are also present in the TG3 structure (PDB ID: 1NUD). As the radius of the previously applied
di- or trivalent cations are very close to each other, one can assume that beside the main site, the
interfacial site of the homodimer (Asp270, Asp271 of both subunits) can also bind Ca2+ not only
Yb3+, and other sites can also exist. 
For the analysis of Ca2+ binding properties of FXIII-A2, our examination was driven by three
main goals; (1) critically evaluate occupancy at the main binding sites of A subunits during the
simulations; (2) validate the existence of weak binding sites proposed earlier and also if they exist,
shed light on their locations;  (3) investigate the impact of extreme high Ca2+ concentration used
during in vitro activation.
Based on our simple MD simulations several possible binding sites have been identified,
with most of them being formed by either spatially close or consecutive negatively charged side-
chains. We have applied a selection criteria in order to reduce the number of possible binding sites
and to remove temporary or weak binding modes. This meant that only those carboxylate carbon
containing residues were collected which had a calcium ion within 4.5 Å and the ion also stayed
within this threshold in more than 5 % of the total simulation time. The full numerical analysis of
calcium binding can be found in the SI as an ASCII log file. Here we discuss primarily the results of
ii/a (FXIII-A2’, 1GGU + 14 mM Ca2+) and ii/c (FXIII-A2’, 1F13 + 14 mM Ca2+) simulations and
preferably  underline  those sites  which  are  most  likely  to  be  conserved in  FXIII-A,  TG2,  TG3
enzymes (Fig. 6). The detailed binding-event analysis can be found in the SI for each simulation
systems (Fig. S16-S20).
Both ii/a and ii/c systems are equally important for understanding calcium binding. It  is
important to note, despite the initial structure of ii/c not containing any bound calciums, that after a
few tenths ns of simulation time one of its main sites becomes occupied and the Ca2+ ion preserves
its position throughout the whole simulation, while the other monomer does not bind any calciums
at all in that place. 
In a preliminary simulation, what was conducted under the very same conditions as in ii/c,
both main sites were filled. In this particular case, the major site of chain A has been filled after 500
ns and after 900 ns both sites contained bound calciums (Fig.  S19.).  The protonation states of
titratable residues were not predicted in this case, which ultimately lead to the binding of multiple
calciums at the interfacial site (Asp270, Asp271 and Glu272 of both subunits). 
The main sites of ii/a appear to bind the calciums quite tightly, even though the Pro505-
Arg515 loops were remodelled based on how they were found in the 1F13 structure. Thus, we can
assume that the loop conformation does not influence the calcium binding at all and, as it can be
seen in Fig. S24, there is no clear connection between the secondary structures of these loops and
the calcium binding events. Comparing the geometries of main sites in the ii/a and ii/c simulations,
we can see an almost identical arrangement in their cluster representations (Fig. 7). Throughout the
simulations  the remodelled loop regions preserved their  initial  structure other  than some minor
changes (Fig. S24), as one of them became almost completely disordered while the other one still
contained a one turn helix element. Based on this information it is unclear whether the loop regions
have any other role over the  in vivo activation or they are just in a fine equilibrium between the
disordered and the one-turn helix arrangements.
In the i/b and ii/b simulations those major sites were occupied, all of which belongs to chain
B, while in the simulation system of the AP free protein model (iii/b) the main site of chain A was
found to bind one calcium ion. The extreme high calcium load (iii/c) caused the binding of at least
one calcium ion per binding site in both A subunits. Thus, a straight conclusion cannot be drawn
concerning these seemingly random preferences based on these relatively long equilibrium MD
simulations. 
In  order  to  study this  “blind  spot”  in  great  detail,  17 simulations  were performed with
different  initial  seeds,  starting  from the  last  frame of  ii/c  by  keeping  the  bound calciums and
resolvating the system in the presence of 100 mM Ca2+, each one lasting 25 ns. In only one out of
the 17 simulations the second site has become filled after 11 ns of simulation time (Fig. S23). We
assume that  this  latent  preference comes from the  stochastic  nature  of  the simulations  and the
random ion placement. 
Figure 6. Calculated calcium binding events during the (A) ii/a (1GGU, cleaved APs, + 14 mM
Ca2+) and (B) ii/c simulations (1F13, cleaved APs, + 14 mM Ca2+). (The coloured thin vertical bars
represent the binding events as a function of simulation time in every row. The frequent binding
events form continuous horizontal  stripes which can be considered as a stronger binding at  the
corresponding  residue.  Different  colours  were  applied  in  order  to  help  the  interpretation  and
comparison of results.)
The second binding site which became occupied quite frequently in our simulations, formed
by Asp270 and Asp271 of the monomers and mentioned earlier as an interfacial site, is known to be
able to accommodate Yb3+ ions while these aspartates also bind the Ca2+ ions in the 4KTY (non-
proteolitically activated) structure (Stieler et al., 2013) of factor XIII-A and in the transglutaminase
3 (TG3) (PDB ID: 1NUD) (Ahvazi, Boeshans, Idler, Baxa, & Steinert, 2003). Our results suggest
that in this site at least one bound calcium ion can always be found. The prediction of protonation
states suggests that the sidechain of Glu272 is possibly protonated and, dependent on its protonation
state, is able to bind up to two calcium ions. Despite our significant efforts, the role of this site is
still not fully understood, although these loop regions are quite flexible and therefore can easily
adapt a conformation that can be seen in the 4KTY or 1NUD structures. It is important to note that
this  region  is  situated  very  close  to  the  central  salt-bridge  network,  so  we  cannot  exclude  its
regulatory role over the whole activation process. Also, these sites are directly connected with the
loops between Ser278-Gly294 of the A subunits, which serve as the boundary between the active
site and the partially neighbouring β-barrel-2.
The third calcium binding site, which is also present in 4KTY and in 1NUD, can be found
under  the activation peptide and is  formed by the side-chains  of Asp343, Asp345, Asp351 and
Asp367. This site was not easily accessible while the AP was in its place and the Asp343, Asp367
residues were in direct contact with the guanidium group of the side-chains of Arg11 and Arg12,
therefore binding was not possible at this site. However, in the iii/b simulation a calcium can be
found near the Asp343 and Asp345 of the A chain, with the dimer structure remaining intact and the
other two residues being further away, so additional changes would be required for binding to occur
at this site. As mentioned above, the extreme high calcium concentration (iii/c) induces notable
changes in the overall position of the A subunits compared to each other. It seems that in both main
chains the site  is  formed after 250 ns of simulation and additionally almost  all  of the possible
anionic surface sites became occupied (Fig. S18(B)). Sites with reduced affinity (Glu355, Glu356,
Asp357; Asp521, Glu523, Glu525; Asp574, Glu585, Glu614; Asp472, Glu631, Glu720, Asp722)
may also be important in the non-proteolytic activation. We suggest that the reason why extreme
high ionic strength is able to cause large scale monomer rotation is probably due to the breakdown
of the electrostatic interactions between the A subunits. On the other hand, it remains unclear what
causes the separation of the β-barrels from the catalytic core domain. In fact, the site formed by
Asp472, Glu631, Glu720 and Asp722 represents an interdomain contact between the β-barrel 2 and
the core domain.
An important question could be whether the simplified molecular mechanics parameters of
divalent cations are able to predict the geometries of binding sites appropriately? To try and answer
this  question,  we have decided to continue the ii/c simulation for a further 50 ns NpT MD by
replacing the bound calciums to multi-site calcium models in order to validate the geometries of the
already established binding sites. Our results suggest that all sites preserve their potency perfectly
(Fig. S21) and the final frame of the simulation is included in the SI as a pdb file, which also
contains the water molecules coordinated to the bound calcium ions.
It  is  worth mentioning that  at  least  five binding sites were identified in the case of v/a
(4KTY, 14 mM Ca2+) (Fig. S20) and each one binds its calcium ion continuously, while in the
zymogen or  cleaved systems some of  these sites  seem to have  somewhat  weaker  potency (eg.
Asp138, Glu139 or Glu355, Glu356, Asp357).
Our work supports the presence of two new binding sites with distinguished importance
beside the main Ca2+ binding site of the A subunits.  The first  one is  formed by the very same
Asp270 and Asp271 residues of the A subunits and hence can be realized as an inter-subunit site
which was known earlier as a place suitable for binding Yb3+ ions. The second site has a more
complex structure and will be relevant only in the absence of APs. This site can be established by
the  contribution  of  Asp343,  Asp345,  Asp351  and Asp367  residues  of  the  A subunits  after  the
dissociation of APs. Moreover, this site can be formed only in the presence of extremely high Ca2+
concentration where rotation of the A subunits occurs. This site can also be found in the active
FXIII-AO (v/a) which enhances its relevance even further.
Figure 7. Main binding sites of FXIII-A2 in the cluster representatives after clustering the dynamic
trajectories. The results of simulation ii/a (A) and the results of simulation ii/d (B). (The secondary
structure elements of FXIII-A2 was represented as “cartoons”, the important residues of main sites
were shown as “ball and stick” models and the bound calciums were depicted with green spheres.)
TG2
Based  on  site-directed  mutagenesis  studies,  five  out  of  six  binding  sites  of  TG2  were
identified. Despite the significant efforts of this work, the static snapshot used as starting point,
provided by X-ray crystallography, was lacking the true dynamic behaviour of proteins  in vivo,
nevertheless,  MD simulations  provide  a  good insight  to  study these  time-resolved atomic-level
events. Our detailed work serves multiple purposes; (1) since such detailed mutagenesis studies are
not available for FXIII-A2, it was important to compare the results of our microsecond long MD
simulations  to in vitro experiments and TG2 embodies a perfect target for such a purpose; (2) we
wished to review the relevance of previously identified binding sites and also intended to identify
the missing sixth site of TG2. Instead of plotting binding events alone, we have concentrated on the
representation of distances between the carboxylate carbon atom of acidic residues and the calcium
ions. In the following we use the site labelling suggested by Király et al. (Király et al., 2009).
The calcium binding features of GDP bound TG2 (iv/d) is depicted in Figure 8. and the
location of the binding sites on the protein can be seen in Figure 9, using the same panel labelling as
in Figure 8.
Compared to in vitro results and static modelling, an important difference is that at least two
sites exist on the β-sandwich domain (Fig. 8(A, B, C, D, E)). In the case of the GTP bound form of
TG2 (iv/e) these sites appear much less significant (Fig. S26(A, B, C, D, E)). In agreement with
previous experiments, the S1 site was also found in all of the simulations except in iv/b (GDP-free).
It should be noted that this is formed via the contribution of the Asp232 and Asp233 residues (Fig.
8(G), Fig. S26(E), Fig. S27(F)). Concerning the acidic residues of the S2A site, we can see that the
sidechain of Glu396 orientates to the inner side of the core domain and therefore is buried within.
Besides Glu396, there is another negatively charged residue located at this site, Asp400. In the case
of iv/a-d the distance between the Cγ of Asp400 and the Nζ of Lys464 is 5.55 ± 1.25 Å on average,
which does not deviate considerably during the production runs. Comparing this value to those
which  can  be  calculated  in  the  case  of  ii/a-d  (FXIII-A2’),  the  corresponding  residues  are
significantly further apart (6.25 ± 1.30 Å), thus the shorter distance can be attributed to the salt-
bridge blocking of the Asp400 sidechain.  Instead of the S2A and S2B sites a new site has been
identified with a high rate of occupancy. By the residues of Glu381, Glu451 and Glu454 a new site
can  be  formed  (Fig.  8(J),  Fig.  S25(I),  Fig.  S27(E))  and  the  occupancy  of  this  site  is  almost
continuous in  every case.  A second new site  has also been formed by the residues of Glu319,
Asp408  and  Asp409  (Fig.  8(I),  Fig.S25(H),  Fig.  S27(H)).  It  is  worth  noting  that  in  the  open
conformation the Asp581 takes part  in the formation of this site.  The Glu467, Glu469, Glu470
residues of the 460s loop have weak binding affinity and the simulation with multi-site calcium
models also confirm that the Ca2+ remains close to Glu467 and Glu470 (Fig. 8(L), Fig. S25(K), Fig.
S26(G), Fig. S29). Two additional binding sites, namely the S3A and S3B, were proposed with one
acidic residue in each. It has been found that both amino acids bind the same calcium ion and, in the
minority of the simulation time, the Glu363 also contributes to the binding (Fig. 8(H), Fig. S26(F),
Fig. S27(G)). The S4 site is composed from the consecutive five acidic residues between Asp151
and Glu158. 
Figure 8. Calcium binding of TG2 during the iv/d simulation. (The distance between any calcium
ion and the corresponding carboxylate  carbon atom was calculated.  The protein segments were
represented with coloured “cartoons” and the corresponding negatively charged side-chains were
shown with “sticks”. The bound calciums can be seen as green spheres.)
Figure 9.  The location of Ca2+-binding sites in TG2. ((A),  front view, (B),  back view. The site
labelling used is the same as Fig. 8. The colouring of cartoons is the same as it was in the case of
Figure 8.)
Our simulations are in good agreement with experimental results, meaning that Asp151 and Glu155
seem to be an appropriate diad for binding calcium ions (Fig. 8(F), Fig. S26(C), Fig. S25(F), Fig.
S27(D)). On top of the already known sites a new one has also been identified, formed by Asp640,
Glu643 and Glu646 in every case (Fig. 8(K), Fig. S26(J), Fig. S25(J), Fig. S27(K)). This site was
almost continuously occupied, independently from the simulation systems, hence we reckon that it
is the sixth site of TG2.
Similarly to the FXIII-A2 simulation, iv/d was continued for a further 50 ns using multi-site
calcium models and the majority of the ion binding contacts remained unchanged (Fig. S29). The
final frame of this simulation can be found in the SI. 
Regarding the calcium binding properties of TG2, based on our recent results, the following
conclusions can be made on the calcium binding sites of TG2 compared to the experimental results
by Király et al. (Király et al., 2009). The S1, S3A/S3B and S4 sites are found to be suitable for
binding calciums in our simulations,  ie.  they support  the experimental  findings and  vice versa,
however opposing results have been found regarding the S2A/S2B and S5 sites. The S2A/S2B sites
correspond to the main site of FXIII-A where we have observed the binding of Ca2+ during the 1 or
2 μs long simulations without APs (iii/a-c) shows long simulations, but no binding event has happened in the case of TG2.  In respect to the S5
site we have also found that this site has no significance in the early stage of activation. We cannot
rule out that in a later phase of the activation process the significance of these sites will increase,
but starting from crystallographic structures even during these relatively long MD simulations we
were unable to observe binding events at these places. Instead of the S2A/S2B and S5 sites we
suggest  the  presence  two other  sites  near  the  residues  of  Glu381,  Glu451,  Glu454 and by the
Glu319, Asp408, Asp409. Finally, a strong binding site was identified formed by the contribution of
Asp640, Glu643 and Glu646 residues. Due to its outstanding binding affinity we consider it as the
previously unknown, sixth calcium binding site (S6) of TG2.
The results of the calcium binding properties study of TG2 are not only clarify the existence
of its Ca2+ binding sites, but also to indirectly support our findings and observations which were
made in the case of FXIII-A2.
Conclusion
A series of microsecond long all-atom MD simulation were carried out in order to clarify the
important details which may initiate the activation of the studied TGs and are primarily linked to the
binding of calcium ions to blood coagulation factor XIII-A2 and TG2. 
In the case of the dimer A subunit of blood coagulation factor XIII we have found that the
calcium concentration increases the flexibility of the N-terminals of the APs and three calcium
binding sites were identified with possible  significance in  the activation mechanism. The main
binding site of FXIII-A2 was known and based on our work it was found that binding events can be
observed in at least one of the main sites on the studied 1 or 2 μs long simulations without APs (iii/a-c) shows long timescale. In those models
which were based on 1GGU (Ca2+ bound crystallographic structure), the calcium ions preserved
their position throughout all of the simulations, thus these sites can be considered strong binding
sites. Suggestions have been made for the possible significance of the binding site near Asp270 and
Asp271 of both subunits during the activation procedure. A third binding site was identified, which
has possible importance only in the absence of APs and the rotation of A subunits are needed to
form this site (Asp343, Asp345, Asp351 and Asp367). It should be noted that this site was known in
the case of TG3 already, and simulation with the open FXIII-A also confirmed the existence of this
site.
It was also pointed out that in the absence of APs the high Ca2+ concentration (1000 mM)
was able to cause large scale monomer movements, probably by breaking down the intermolecular
electrostatic interactions. The calculated PCA eigenvectors predict this rotation even in the absence
of any calcium ions and this finding is supported directly by  in vivo experiments in the case of
zymogen structures, if we assume that the high ionic strength causes immediate dissociation of APs.
The calcium binding ability of TG2, a structurally very similar protein although with other
distinct functions, was also investigated using in silico modelling methods, based on the profound
work of  Király  and co-workers.  Our  current  work  provides  further  evidence  on  most  of  these
proposed sites, however in a few cases results from our simulation studies seem to point to different
conclusions. According to the labelling of the binding sites of Király et al., the S1, S3A/S3B and S4
sites  are  in  good agreement  with the  results  of  previously  conducted  in  vitro studies,  however
instead of S2A/S2B we would like to propose another site which can be formed by the contribution
of Glu381, Glu451 and Glu454 in this early phase of activation. Based on our work, we could not
confirm whether the S5 site really is appropriate or not for binding a calcium ion. Among other
possible and earlier unknown binding sites, another site was also identified which can be formed by
the Asp640, Glu643 and Glu646 residues and found to be frequently populated by a calcium ion
during the MD simulations. Thus this has been identified as the sixth (S6), previously unknown
binding site of TG2.
Supplementary material
Acknowledgements
The authors truly appreciate the computational resources made available on the Debrecen2
(Leo)  GPU cluster  of  the Governmental  Information-Technology Development  Agency.  We are
thankful to Prof. László Muszbek for his helpful comments. Molecular graphics and analyses were
performed  with  the  UCSF  Chimera  package.  Chimera  is  developed  by  the  Resource  for
Biocomputing,  Visualization,  and  Informatics  at  the  University  of  California,  San  Francisco
(supported by NIGMS P41-GM103311).
Funding
This work was supported by the Hungarian Scientific Research Fund (OTKA K-106294). AF is also
thankful for the PhD scholarship to the Richter Gedeon Talentum Foundation. The work at Swetox
(DM) was supported by Knut and Alice Wallenberg Foundation [2013.0253] and Swedish Research
Council FORMAS [2016–02031].
References
Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). 
GROMACS: High performance molecular simulations through multi-level parallelism from 
laptops to supercomputers. SoftwareX, 1–2, 19–25. 
https://doi.org/10.1016/j.softx.2015.06.001
Ahvazi, B., Boeshans, K. M., Idler, W., Baxa, U., & Steinert, P. M. (2003). Roles of Calcium Ions in
the Activation and Activity of the Transglutaminase 3 Enzyme. Journal of Biological 
Chemistry, 278(26), 23834–23841. https://doi.org/10.1074/jbc.M301162200
Ambrus, A., Bányai, I., Weiss, M. S., Hilgenfeld, R., Keresztessy, Z., Muszbek, L., & Fésüs, L. 
(2001). Calcium Binding of Transglutaminases: A 43 Ca NMR Study Combined with Surface
Polarity Analysis. Journal of Biomolecular Structure and Dynamics, 19(1), 59–74. 
https://doi.org/10.1080/07391102.2001.10506720
Anandakrishnan, R., Aguilar, B., & Onufriev, A. V. (2012). H++ 3.0: automating pK prediction and 
the preparation of biomolecular structures for atomistic molecular modeling and 
simulations. Nucleic Acids Research, 40(W1), W537–W541. 
https://doi.org/10.1093/nar/gks375
Bakan, A., Dutta, A., Mao, W., Liu, Y., Chennubhotla, C., Lezon, T. R., & Bahar, I. (2014). Evol and
ProDy for bridging protein sequence evolution and structural dynamics. Bioinformatics, 
30(18), 2681–2683. https://doi.org/10.1093/bioinformatics/btu336
Bakan, A., Meireles, L. M., & Bahar, I. (2011). ProDy: Protein Dynamics Inferred from Theory and 
Experiments. Bioinformatics, 27(11), 1575–1577. 
https://doi.org/10.1093/bioinformatics/btr168
Bergamini, C. M. (1988). GTP modulates calcium binding and cation-induced conformational 
changes in erythrocyte transglutaminase. FEBS Letters, 239(2), 255–258. 
https://doi.org/10.1016/0014-5793(88)80928-1
Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. 
The Journal of Chemical Physics, 126(1), 014101. https://doi.org/10.1063/1.2408420
Casadio, R., Polverini, E., Mariani, P., Spinozzi, F., Carsughi, F., Fontana, A., … Bergamini, C. M. 
(1999). The structural basis for the regulation of tissue transglutaminase by calcium ions. 
European Journal of Biochemistry, 262(3), 672–679.
Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., … Woods, R. J. (2005).
The Amber biomolecular simulation programs. Journal of Computational Chemistry, 
26(16), 1668–1688. https://doi.org/10.1002/jcc.20290
Credo, R. B., Curtis, C. G., & Lorand, L. (1978). Ca2+-related regulatory function of fibrinogen. 
Proceedings of the National Academy of Sciences, 75(9), 4234–4237. 
https://doi.org/10.1073/pnas.75.9.4234
D.A. Case, R.M. Betz, D.S. Cerutti, T.E. Cheatham III, T.A. Darden, R.E. Duke, … P.A. Kollman. 
(2016). AMBER 2016. University of California, San Francisco. Retrieved from 
http://ambermd.org
Droettboom, M., Caswell, T. A., Hunter, J., Firing, E., Nielsen, J. H., Lee, A., … Würtz, P. (2018 
17). Matplotlib/Matplotlib V2.2.2. Zenodo. https://doi.org/10.5281/zenodo.1202077
Fizil, Á., Sonderegger, C., Czajlik, A., Fekete, A., Komáromi, I., Hajdu, D., … Batta, G. (2018). 
Calcium binding of the antifungal protein PAF: Structure, dynamics and function aspects by 
NMR and MD simulations. PLOS ONE, 13(10), e0204825. 
https://doi.org/10.1371/journal.pone.0204825
Fox, B. A., Yee, V. C., Pedersen, L. C., Le Trong, I., Bishop, P. D., Stenkamp, R. E., & Teller, D. C. 
(1999). Identification of the calcium binding site and a novel ytterbium site in blood 
coagulation factor XIII by x-ray crystallography. The Journal of Biological Chemistry, 
274(8), 4917–4923.
Gordon, J. C., Myers, J. B., Folta, T., Shoja, V., Heath, L. S., & Onufriev, A. (2005). H++: a server 
for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids 
Research, 33(Web Server), W368–W371. https://doi.org/10.1093/nar/gki464
Grant, B. J., Rodrigues, A. P. C., ElSawy, K. M., McCammon, J. A., & Caves, L. S. D. (2006). 
Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics, 
22(21), 2695–2696. https://doi.org/10.1093/bioinformatics/btl461
Gupta, S., Biswas, A., Akhter, M. S., Krettler, C., Reinhart, C., Dodt, J., … Oldenburg, J. (2016). 
Revisiting the mechanism of coagulation factor XIII activation and regulation from a 
structure/functional perspective. Scientific Reports, 6(1). https://doi.org/10.1038/srep30105
Han, B.-G., Cho, J.-W., Cho, Y. D., Jeong, K.-C., Kim, S.-Y., & Lee, B. I. (2010). Crystal structure 
of human transglutaminase 2 in complex with adenosine triphosphate. International Journal
of Biological Macromolecules, 47(2), 190–195. 
https://doi.org/10.1016/j.ijbiomac.2010.04.023
Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint 
solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. 
https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison 
of multiple Amber force fields and development of improved protein backbone parameters. 
Proteins: Structure, Function, and Bioinformatics, 65(3), 712–725. 
https://doi.org/10.1002/prot.21123
Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of 
Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
Jang, T.-H., Lee, D.-S., Choi, K., Jeong, E. M., Kim, I.-G., Kim, Y. W., … Park, H. H. (2014). 
Crystal Structure of Transglutaminase 2 with GTP Complex and Amino Acid Sequence 
Evidence of Evolution of GTP Binding Site. PLoS ONE, 9(9), e107005. 
https://doi.org/10.1371/journal.pone.0107005
Kanchan, K., Ergülen, E., Király, R., Simon-Vecsei, Z., Fuxreiter, M., & Fésüs, L. (2013). 
Identification of a specific one amino acid change in recombinant human transglutaminase 2
that regulates its activity and calcium sensitivity. Biochemical Journal, 455(3), 261–272. 
https://doi.org/10.1042/BJ20130696
Kanchan, K., Fuxreiter, M., & Fésüs, L. (2015). Physiological, pathological, and structural 
implications of non-enzymatic protein–protein interactions of the multifunctional human 
transglutaminase 2. Cellular and Molecular Life Sciences, 72(16), 3009–3035. 
https://doi.org/10.1007/s00018-015-1909-z
Király, R., Csősz, É., Kurtán, T., Antus, S., Szigeti, K., Simon-Vecsei, Z., … Fésüs, L. (2009). 
Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 
2 characterized by site-directed mutagenesis: Ca2+-binding sites of TG2. FEBS Journal, 
276(23), 7083–7096. https://doi.org/10.1111/j.1742-4658.2009.07420.x
Komáromi, I., Bagoly, Z., & Muszbek, L. (2011). Factor XIII: novel structural and functional 
aspects: FXIII: structure and function. Journal of Thrombosis and Haemostasis, 9(1), 9–20. 
https://doi.org/10.1111/j.1538-7836.2010.04070.x
Lai, T. S., Slaughter, T. F., Peoples, K. A., & Greenberg, C. S. (1999). Site-directed mutagenesis of 
the calcium-binding site of blood coagulation factor XIIIa. The Journal of Biological 
Chemistry, 274(35), 24953–24958.
Li, D.-W., & Brüschweiler, R. (2010). NMR-Based Protein Potentials. Angewandte Chemie 
International Edition, 49(38), 6778–6780. https://doi.org/10.1002/anie.201001898
Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. 
(2010). Improved side-chain torsion potentials for the Amber ff99SB protein force field. 
Proteins: Structure, Function, and Bioinformatics, NA-NA. 
https://doi.org/10.1002/prot.22711
Liu, S., Cerione, R. A., & Clardy, J. (2002). Structural basis for the guanine nucleotide-binding 
activity of tissue transglutaminase and its regulation of transamidation activity. Proceedings 
of the National Academy of Sciences, 99(5), 2743–2747. 
https://doi.org/10.1073/pnas.042454899
Lorand, L. (2001). Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. 
Annals of the New York Academy of Sciences, 936, 291–311.
Lorand, L., & Konishi, K. (1964). ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF 
PLASMA BY THROMBIN. Archives of Biochemistry and Biophysics, 105, 58–67.
McCammon, J. A. (1984). Protein dynamics. Reports on Progress in Physics, 47(1), 1–46. 
https://doi.org/10.1088/0034-4885/47/1/001
Meagher, K. L., Redman, L. T., & Carlson, H. A. (2003). Development of polyphosphate 
parameters for use with the AMBER force field. Journal of Computational Chemistry, 
24(9), 1016–1025. https://doi.org/10.1002/jcc.10262
Muszbek, L., Ariëns, R. A., Ichinose, A., & ON BEHALF OF THE ISTH SSC SUBCOMMITTEE 
ON FACTOR XIII. (2007). Factor XIII: recommended terms and abbreviations: Factor XIII.
Journal of Thrombosis and Haemostasis, 5(1), 181–183. https://doi.org/10.1111/j.1538-
7836.2006.02182.x
Muszbek, László, Bereczky, Z., Bagoly, Z., Komáromi, I., & Katona, É. (2011). Factor XIII: A 
Coagulation Factor With Multiple Plasmatic and Cellular Functions. Physiological Reviews, 
91(3), 931–972. https://doi.org/10.1152/physrev.00016.2010
Myers, J., Grothaus, G., Narayanan, S., & Onufriev, A. (2006). A simple clustering algorithm can be
accurate enough for use in calculations of pKs in macromolecules. Proteins: Structure, 
Function, and Bioinformatics, 63(4), 928–938. https://doi.org/10.1002/prot.20922
Páll, S., Abraham, M. J., Kutzner, C., Hess, B., & Lindahl, E. (2015). Tackling Exascale Software 
Challenges in Molecular Dynamics Simulations with GROMACS. In S. Markidis & E. 
Laure (Eds.), Solving Software Challenges for Exascale (Vol. 8759, pp. 3–27). Cham: 
Springer International Publishing. https://doi.org/10.1007/978-3-319-15976-8_1
Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular 
dynamics method. Journal of Applied Physics, 52(12), 7182–7190. 
https://doi.org/10.1063/1.328693
Pedersen, L. C., Yee, V. C., Bishop, P. D., Trong, I. L., Teller, D. C., & Stenkamp, R. E. (1994). 
Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink 
macromolecules. Protein Science, 3(7), 1131–1135. https://doi.org/10.1002/pro.5560030720
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & 
Ferrin, T. E. (2004). UCSF Chimera?A visualization system for exploratory research and 
analysis. Journal of Computational Chemistry, 25(13), 1605–1612. 
https://doi.org/10.1002/jcc.20084
Pinkas, D. M., Strop, P., Brunger, A. T., & Khosla, C. (2007). Transglutaminase 2 Undergoes a 
Large Conformational Change upon Activation. PLoS Biology, 5(12), e327. 
https://doi.org/10.1371/journal.pbio.0050327
Polgár, J., Hidasi, V., & Muszbek, L. (1990). Non-proteolytic activation of cellular 
protransglutaminase (placenta macrophage factor XIII). The Biochemical Journal, 267(2), 
557–560.
R Core Team. (2013). R: A Language and Environment for Statistical Computing. Vienna, Austria: 
R Foundation for Statistical Computing. Retrieved from http://www.R-project.org/
Roe, D. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for Processing and 
Analysis of Molecular Dynamics Trajectory Data. Journal of Chemical Theory and 
Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
Šali, A., & Blundell, T. L. (1993). Comparative Protein Modelling by Satisfaction of Spatial 
Restraints. Journal of Molecular Biology, 234(3), 779–815. 
https://doi.org/10.1006/jmbi.1993.1626
Salomon-Ferrer, R., Case, D. A., & Walker, R. C. (2012). An overview of the Amber biomolecular 
simulation package. Wiley Interdisciplinary Reviews: Computational Molecular Science, 
3(2), 198–210. https://doi.org/10.1002/wcms.1121
Saxena, A., & Sept, D. (2013). Multisite Ion Models That Improve Coordination and Free Energy 
Calculations in Molecular Dynamics Simulations. Journal of Chemical Theory and 
Computation, 9(8), 3538–3542. https://doi.org/10.1021/ct400177g
Stieler, M., Weber, J., Hils, M., Kolb, P., Heine, A., Büchold, C., … Klebe, G. (2013). Structure of 
Active Coagulation Factor XIII Triggered by Calcium Binding: Basis for the Design of 
Next-Generation Anticoagulants. Angewandte Chemie International Edition, 52(45), 11930–
11934. https://doi.org/10.1002/anie.201305133
Takagi, T., & Doolittle, R. F. (1974). Amino acid sequence studies on factor XIII and the peptide 
released during its activation by thrombin. Biochemistry, 13(4), 750–756. 
https://doi.org/10.1021/bi00701a018
Turner, B. T., & Maurer, M. C. (2002). Evaluating the Roles of Thrombin and Calcium in the 
Activation of Coagulation Factor XIII Using H/D Exchange and MALDI-TOF MS †. 
Biochemistry, 41(25), 7947–7954. https://doi.org/10.1021/bi025630n
van der Walt, S., Colbert, S. C., & Varoquaux, G. (2011). The NumPy Array: A Structure for 
Efficient Numerical Computation. Computing in Science & Engineering, 13(2), 22–30. 
https://doi.org/10.1109/MCSE.2011.37
Weiss, M. S., Metzner, H. J., & Hilgenfeld, R. (1998). Two non-proline cis peptide bonds may be 
important for factor XIII function. FEBS Letters, 423(3), 291–296.
Yang, Z., Lasker, K., Schneidman-Duhovny, D., Webb, B., Huang, C. C., Pettersen, E. F., … Ferrin, 
T. E. (2012). UCSF Chimera, MODELLER, and IMP: An integrated modeling system. 
Journal of Structural Biology, 179(3), 269–278. https://doi.org/10.1016/j.jsb.2011.09.006
Yee, V. C., Pedersen, L. C., Le Trong, I., Bishop, P. D., Stenkamp, R. E., & Teller, D. C. (1994). 
Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. 
Proceedings of the National Academy of Sciences of the United States of America, 91(15), 
7296–7300.
Yee, Vivien C., Pedersen, L. C., Bishop, P. D., Stenkamp, R. E., & Teller, D. C. (1995). Structural 
evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. 
Thrombosis Research, 78(5), 389–397. https://doi.org/10.1016/0049-3848(95)00072-Y
